What is Shandong Weigao Group Medical Polymer Co EBITDA Margin %?
Shandong Weigao Group Medical Polymer CoSHWGY 70 EBITDA Margin % is 14.01% as of Dec. 2025, which is 52% below its 10-year median of 29.28. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.17 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Shandong Weigao Group Medical Polymer Co ranks better than 70.22% on this metric.
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shandong Weigao Group Medical Polymer Co EBITDA Margin % Related Terms
Shandong Weigao Group Medical Polymer Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co EBITDA Margin % Chart
Shandong Weigao Group Medical Polymer Co Annual Data
SHWGY vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co (SHWGY) has a EBITDA Margin % of 14.01% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. This is 52% below median its historical median of 29.28. Over the past decade, Shandong Weigao Group Medical Polymer Co's EBITDA Margin % has ranged from 17.07 to 31.86. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #243 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is Shandong Weigao Group Medical Polymer Co's EBITDA Margin % too high?
Shandong Weigao Group Medical Polymer Co's current EBITDA Margin % of 14.01% is 52% below median its 10-year median of 29.28. Over the past 10 years, this metric has ranged from a low of 17.07 to a high of 31.86. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Shandong Weigao Group Medical Polymer Co's value of 14.01% is 87.4% above this industry median. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #243 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #243 out of 816 companies for EBITDA Margin %. This puts Shandong Weigao Group Medical Polymer Co in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Shandong Weigao Group Medical Polymer Co's value of 14.01% is 87.4% above this benchmark. Historically, Shandong Weigao Group Medical Polymer Co's own EBITDA Margin % has ranged from 17.07 to 31.86 over the past decade. While the company's 10-year median is 29.28 vs. the industry median of 7.48, Shandong Weigao Group Medical Polymer Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current EBITDA Margin % of 14.01% is 87.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current EBITDA Margin % is 14.01%, which is 52% below median its own 10-year median of 29.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.17, compared to a current price of $1.58 — trading 50.2% below its estimated fair value. The current EBITDA Margin % is 14.01%, which is 52% below median its 10-year median of 29.28 and 87.4% above the Medical Devices & Instruments industry median of 7.48. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current EBITDA Margin % is 14.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $1.58 is trading 50.2% below its estimated GF Value™ of $3.17.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGY:
EBITDA Margin %: 14.01% (52% below median its 10-year median of 29.28)
GF Value™: $3.17 vs. price of $1.58 (50.2% below fair value)
Industry Position: 87.4% above the Medical Devices & Instruments median (#243 of 816)
No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score
Get the complete analysis for SHWGY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGY has been successfully added to your 
